NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Galecto Inc (NASDAQ: GLTO)

 
GLTO Technical Analysis
1.5
As on 9th Jun 2023 GLTO STOCK Price closed @ 2.19 and we RECOMMEND Buy for LONG-TERM with Stoploss of 2.06 & Sell for SHORT-TERM with Stoploss of 2.45 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

GLTOSTOCK Price

Open 2.30 Change Price %
High 2.30 1 Day -0.04 -1.79
Low 2.16 1 Week -0.05 -2.23
Close 2.19 1 Month 0.28 14.66
Volume 29510 1 Year -0.63 -22.34
52 Week High 3.45 | 52 Week Low 1.06
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
GLTO
Daily Charts
GLTO
Intraday Charts
Whats New @
Bazaartrend
GLTO
Free Analysis
 
GLTO Important Levels Intraday
RESISTANCE2.46
RESISTANCE2.37
RESISTANCE2.32
RESISTANCE2.27
SUPPORT2.11
SUPPORT2.06
SUPPORT2.01
SUPPORT1.92
 
GLTO Forecast May 2024
4th UP Forecast4.68
3rd UP Forecast3.88
2nd UP Forecast3.39
1st UP Forecast2.89
1st DOWN Forecast1.49
2nd DOWN Forecast0.99
3rd DOWN Forecast0.5
4th DOWN Forecast-0.3
 
GLTO Weekly Forecast
4th UP Forecast3.37
3rd UP Forecast2.99
2nd UP Forecast2.76
1st UP Forecast2.52
1st DOWN Forecast1.86
2nd DOWN Forecast1.62
3rd DOWN Forecast1.39
4th DOWN Forecast1.01
 
GLTO Forecast2024
4th UP Forecast6.99
3rd UP Forecast5.45
2nd UP Forecast4.5
1st UP Forecast3.55
1st DOWN Forecast0.83
2nd DOWN Forecast-0.12
3rd DOWN Forecast-1.07
4th DOWN Forecast-2.61
 
 
GLTO Other Details
Segment EQ
Market Capital 84606824.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
GLTO Address
GLTO
 
GLTO Latest News
 
Your Comments and Response on Galecto Inc
 
GLTO Business Profile
Galecto, Inc., a clinical-stage biotechnology company, develops molecules for the treatment of fibrosis, cancer, inflammation, and other related diseases. The company's lead product candidate is GB0139, an inhaled inhibitor of galectin-3 that is in Phase IIb clinical trial for the treatment of severe fibrotic lung diseases, such as idiopathic pulmonary fibrosis, a life-threatening progressive fibrotic disease of the lung. Its products also comprise GB2064, which is in Phase I/IIa for the treatment of myelofibrosis; and GB1211, a selective oral galectin-3 inhibitor that is in Phase I/IIa for the treatment of cancer and fibrosis. Galecto, Inc. was founded in 2011 and is based in Boston, Massachusetts. Address: 75 State Street, Boston, MA, United States, 02109
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service